Treatment of postoperative diabetes insipidus should be individualized ( Box 1). Optimally, patients should be monitored for the development of polyuria or hypo-osmolality. Fluid intake and output ...

The diagnosis of diabetes insipidus should be considered when a patient excretes large volumes of dilute urine after neurosurgery, typically >2.5 ml/kg body weight per hour.

These Diabetes Drugs Are Finding New Life as an Antiaging Hack Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer By ...

A new study has found a link between certain midlife vascular risk factors — specifically high blood pressure, diabetes, and smoking — and the risk for dementia.

Blood sugar levels go unnoticed, until they don’t. When they rise beyond normal, it can lead to fatigue, brain fog, and even long-term issues like diabetes. The fascinating part is that certain ...

Stress hormones can raise blood sugar. You can manage stress levels and your mental health to help manage diabetes. If you’re experiencing stress or feeling threatened, your body reacts. This is ...

The American College of Lifestyle Medicine has published the first clinical practice guideline focusing primarily on lifestyle interventions for diabetes treatment and potential remission of type ...

The most common early signs of type 2 diabetes are frequent urination, extreme thirst, and persistent hunger. If you have type 2 diabetes, you might experience tingling or numbness in your hands ...

Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...

Asif M, Asif A, Rahman UA, et al. Incidence of glaucoma in type 2 diabetes patients treated with GLP-1 receptor agonists: a systematic review and meta-analysis. 2025;8:e70059. doi:10.1002/edm2 ...

Overall, 11,758 patients with CKD, diabetes and hypertension were included in the study, of whom 5,864 used insulin and 5,894 did not. After an 11-year follow-up period, researchers found 1,285 ...

CHICAGO — Orforglipron, a novel nonpeptide, small molecule oral GLP-1, reduced HbA1c at 40 weeks for patients with type 2 diabetes, according to results of the phase 3 ACHIEVE-1 trial. ACHIEVE-1 ...